elfabrio
Generic: pegunigalsidase alfa·Code: PRX-102
elfabrio: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | Approved |
Get deeper analysis on elfabrio
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis